# Filippo de Braud

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/filippo-de-braud/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,709 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 103 |
| i10-index | 564 |
| Last Known Institution | University of Milan |
| OpenAlex ID | https://openalex.org/A5009935310 |
| ORCID iD | https://orcid.org/0000-0003-0103-730X |
| Works | 1,554 |

## Researcher papers

- [Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/efficacy-of-selpercatinib-in-i-ret-i-fusion-positive-non-small-cell-lung-cancer/)
- [Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)](https://scholariq.org/papers/safety-and-antitumor-activity-of-the-multitargeted-pan-trk-ros1-and-alk/)
- [Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials](https://scholariq.org/papers/entrectinib-in-ros1-fusion-positive-non-small-cell-lung-cancer-integrated/)
- [Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial](https://scholariq.org/papers/dabrafenib-plus-trametinib-in-patients-with-brafv600e-mutated-biliary-tract/)
- [Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort](https://scholariq.org/papers/nivolumab-monotherapy-and-nivolumab-plus-ipilimumab-in-recurrent-small-cell-lung/)
- [Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression](https://scholariq.org/papers/metastatic-and-locally-advanced-pancreatic-endocrine-carcinomas-analysis-of/)
- [Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population](https://scholariq.org/papers/genomic-context-of-ntrk1-2-3-fusion-positive-tumours-from-a-large-real-world/)
- [Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study](https://scholariq.org/papers/chromogranin-a-as-a-marker-of-neuroendocrine-neoplasia-an-italian-multicenter/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [University of Milan](https://scholariq.org/institutions/university-of-milan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.